At LuminoDx with a commitment to precision medicine, and a combined 35 years of CRO experience, we are at the forefront of driving advancements in liquid biopsy translational science, clinical research, and diagnostics. At LuminoDx we specialize in leveraging cutting edge technologies for exosome isolation and downstream molecular analysis. This includes high content proteomics with O-link’s Signature platform (certified O-link service provider), flow cytometry, and advanced nucleic acid detection platforms like ddPCR.
| Website | https://luminodx.com |
| Employees | 9 (5 on RocketReach) |
| Founded | 2024 |
| Phone | +1 858-333-7527 |
| Industry | Biotechnology Research |
| Keywords | Lab Services, Liquid Biopsy, Research Services, Precision Medicine, Clinical Research, Translational Science, Cancer Diagnostics, Biomarker Discovery, Molecular Diagnostics, Early Cancer Detection, Non-Invasive Diagnostics, Oncology Research, Clinical Trials, Drug Development, Biotechnology, Healthcare, Life Sciences, Medical Research, Health Technology |
| Competitors | Thermo Fisher Scientific, PerkinElmer, Inc., Siemens Healthineers, Roche, Abbott, Agilent Technologies, GE HealthCare, Beckman Coulter Diagnostics, Bio-Rad Laboratories, Illumina +43 more (view full list) |
Looking for a particular LuminoDx Inc. employee's phone or email?
Yipeng Wang is the CEO of LuminoDx Inc..
5 people are employed at LuminoDx Inc..